ClinicalTrials.Veeva

Menu

Quality in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy

U

Uppsala University

Status

Unknown

Conditions

Permanent Hypoparathyroidism

Study type

Observational

Funder types

Other

Identifiers

NCT04998968
2021-01997

Details and patient eligibility

About

Quality of life study. The study with include all patients operated with total thyroidectomy between 2005-2015 in Uppsala-Örebro healthcare region, Sweden. The study population has been identified in a previous study and includes close to 1700 patients, of which about 200 developed permanent hypoparathyroidism after surgery.

Quality of Life will be assessed using SF-36 Health Surgery and the outcome for patients with and without permanent hypoparathyroidism will be compared.

Enrollment

1,700 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Total thyroidectomy between 2005-2015 in Uppsala-Orebro healthcare region.

Exclusion criteria

  • Malignancy
  • Sternotomy
  • Previous thyroid surgery
  • Previous or concurrent parathyroidectomy

Trial design

1,700 participants in 2 patient groups

Patients with permanent hypoparathyroidism after total thyroidectomy
Description:
Patients with permanent hypoparathyroidism after total thyroidectomy for benign thyroid disease. These patients should be operated between 2005-2015 in Uppsala-Örebro healthcare region. Permanent hypoparathyroidism is defined as treatment with Calcium and/or vitamin D more than 12 months after surgery.
Patients without permanent hypoparathyroidism after total thyroidectomy
Description:
Patients without permanent hypoparathyroidism after total thyroidectomy for benign thyroid disease. These patients should be operated between 2005-2015 in Uppsala-Örebro healthcare region.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems